PedAM
Pediatric Disease Annotations & Medicines
| Disease | sudden cardiac death |
| Phenotype | C0376358|prostate cancer |
| Sentences | 2 |
| PubMedID- 26587019 | [9] were the first to report higher risks of cardiovascular and metabolic complications as well as sudden cardiac death in prostate cancer patients receiving adt, whilst short-term adt treatment was significantly associated with greater risks of disease and the elevated risks persisted in men on longer duration therapy [9]. |
| PubMedID- 25896892 | Keating and colleagues, using the surveillance, epidemiology, and end results (seer)–medicare database, reported a 44% increased risk of incident diabetes, a 16% increase in coronary heart disease, an 11% increase in myocardial infarction, and a 16% increase in sudden cardiac death in men with prostate cancer treated with a gonadotropin‐releasing hormone agonist.2 the risk of incident coronary heart disease began 3 months after adt was initiated. |
Page: 1